社区浅静脉血栓患者深静脉血栓与肺栓塞预测模型的开发
本研究基于英国全科诊疗数据库2000—2021年数据,纳入293 166例成人浅静脉血栓(SVT)患者,开发多变量预测模型以识别90天内发生深静脉血栓(DVT)和/或肺栓塞(PE)的高危亚组。结果显示3.5%的患者在90天内发生DVT/PE,51%的DVT/PE在1周内诊断,模型C统计量为0.66(95%CI 0.66-0.67),校准良好(截距=0.04,斜率=1.01),预测风险≥5%的高危患者占9.7%。
要点
- 社区SVT患者90天内DVT/PE发生率为3.5%,51%在1周内诊断。
- 预测风险≥5%的高危患者占9.7%,多有DVT/PE史或为男性伴癌症史。
- 该模型可用于排除血栓并发症并识别需进一步检查或短期抗凝的高危患者。
核心结论
- 社区SVT患者90天内DVT/PE平均风险为3.5%,该简单预测模型性能良好,可用于排除血栓并发症并识别高危亚组。
研究设计与样本
- 基于英国全科诊疗纵向常规护理数据库(Clinical Practice Research Datalink Aurum)2000—2021年数据开发多变量预测模型,纳入293 166例成人SVT患者,中位年龄61岁(IQR 46-73),33%为男性。
- 预设预测因子为生物学性别、年龄、癌症(病史)、DVT/PE病史及无静脉曲张,采用自举法和内部-外部交叉验证评估模型性能。
主要发现
- 293 166例SVT患者中10 301例(3.5%)在90天内发生DVT或PE,51%的DVT/PE在1周内诊断,77%在30天内诊断。
- 模型C统计量为0.66(95%CI 0.66-0.67),校准良好(截距=0.04,斜率=1.01)。
- 预测风险≥5%的高危患者占总人群9.7%,其多有DVT/PE病史或为男性伴癌症(病史)。
关键数值与推荐
- 预测风险≥5%定义为高危亚组,占总人群9.7%。
- 模型C统计量0.66(95%CI 0.66-0.67),校准截距0.04、斜率1.01。
临床怎么用
- 该模型可用于社区SVT患者排除血栓并发症,并识别需进一步诊断检查(针对伴发DVT/PE)和/或短期预防性抗凝治疗的高危患者,以防止血栓进展。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In general practice, superficial venous thrombosis (SVT) is considered a benign condition that does not require anticoagulant treatment. However, a small but not insignificant subgroup of patients will develop serious thrombotic complications, such as deep venous thrombosis (DVT) and/or pulmonary embolism (PE). Tailored anticoagulant treatment in high-risk patients might prevent these complications, yet tools for clinical decision-making are currently lacking. OBJECTIVES: To develop a multivariable prediction model to identify specific SVT subgroups at higher or lower risk of developing DVT/PE to aid clinical decision-making. METHODS: Data from general practices in the longitudinal routine care UK Clinical Practice Research Datalink Aurum database were used in this study, covering the period from 2000 to 2021. A multivariable prediction model was developed for adult SVT patients to predict the outcome of DVT and/or PE within 90 days after the first consultation for SVT. Prespecified predictors were biological sex, age, (history of) cancer, history of DVT/PE, and absence of varicose veins. The model's performance was evaluated using bootstrapping and internal-external cross-validation. RESULTS: Of all identified patients with SVT (N = 293 166; median age, 61 years [IQR, 46-73]; 33% male), 10 301 (3.5%) developed DVT or PE within 90 days. The risk was highest in the first days after the SVT consultation: 51% of DVTs/PEs were diagnosed within 1 week, and 77% within 30 days. The C-statistic of the model was 0.66 (95% CI, 0.66-0.67), and the model showed good calibration (intercept = 0.04, slope = 1.01). High-risk patients with a predicted risk of ≥5% (9.7% of the total population) had a history of DVT/PE or were male with (a history of) cancer. CONCLUSION: In community SVT patients, the average risk of DVT/PE development within 90 days of follow-up is 3.5%. This simple prediction model showed good performance in predicting the short-term risk of DVT/PE and could be used to rule out thrombotic complications in this setting, but also to identify a subgroup of patients at higher risk in whom further diagnostic testing for concomitant DVT/PE and/or short-term preventive anticoagulant treatment should be considered to prevent clot progression.
引用
- van Royen FS, van Smeden M, van Doorn S, et al. Predicting deep venous thrombosis and pulmonary embolism in community patients with superficial venous thrombosis: a model development study. J Thromb Haemost. 2026. PMID: 42413826. doi:10.1016/j.jtha.2026.06.036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。